Skip to main content
Erschienen in: World Journal of Surgery 4/2014

01.04.2014

Tumor Size Does Not Independently Affect Long-Term Survival after Curative Resection of Solitary Hepatocellular Carcinoma Without Macroscopic Vascular Invasion

verfasst von: Han Zhang, Shou-Xin Yuan, Shu-Yang Dai, Jin-Min Zhang, Xing Huang, Chong-De Lu, Jun-Hua Lu, Fu-Quan Wu, Wan Yee Lau, Meng-Chao Wu, Tian Yang, Feng Shen

Erschienen in: World Journal of Surgery | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to investigate the prognostic value of tumor size alone on long-term survival and recurrence after curative resection for solitary hepatocellular carcinoma (HCC) without macroscopic vascular invasion.

Methods

A single-center cohort of 615 patients with solitary HCC (a single tumor, without macroscopic vascular invasion or distant metastasis) undergoing curative hepatic resection from 2002 to 2010 was retrospectively studied. Using 2.0, 3.0, 4.0, 5.0, 8.0, and 10.0 cm as cut-off values of tumor size, the overall survival (OS) and recurrence-free survival (RFS) rates were compared between the groups of patients with tumor size up to a certain cut-off value and the groups of patients with tumor size above that cut-off value. Thus, multiple comparisons were done. The prognostic factors of OS and RFS were evaluated using univariate and multivariate analyses.

Results

The median tumor size of all HCCs was 4.0 cm (range 0.9–22.0 cm). The in-hospital mortality rate was 1.0 %, and the overall morbidity rate was 22.3 %. The 1-, 3-, and 5-year OS rates were 96.0, 79.8, and 69.9 %, and the corresponding RFS rates were 83.6, 72.7, and 57.2 %, respectively. On univariate analyses, the 1-, 3-, and 5-year OS and RFS rates were significantly different between the individual two groups of patients as divided by the aforementioned different cut-off values of tumor sizes (all p < 0.05). However, when tumor size was put as a continuous variable into multivariate analysis, it was no longer an independent prognostic factor of OS or RFS after curative resection.

Conclusions

Tumor size did not independently affect long-term survival and recurrence after curative resection of solitary HCC without macroscopic vascular invasion. Therefore, there is no size limit that precludes hepatic resection for solitary HCC, provided the tumor is resectable.
Literatur
1.
3.
Zurück zum Zitat Song TJ, Ip EW, Fong Y (2004) Hepatocellular carcinoma: current surgical management. Gastroenterology 127:S248–260PubMedCrossRef Song TJ, Ip EW, Fong Y (2004) Hepatocellular carcinoma: current surgical management. Gastroenterology 127:S248–260PubMedCrossRef
4.
Zurück zum Zitat Jarnagin W, Chapman WC, Curley S, D’Angelica M, Rosen C, Dixon E, Nagorney D (2010) Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12:302–310 Jarnagin W, Chapman WC, Curley S, D’Angelica M, Rosen C, Dixon E, Nagorney D (2010) Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12:302–310
6.
Zurück zum Zitat Lee NH, Chau GY, Lui WY, King KL, Tsay SH, Wu CW (1998) Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter. Br J Surg 85:1654–1657PubMedCrossRef Lee NH, Chau GY, Lui WY, King KL, Tsay SH, Wu CW (1998) Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter. Br J Surg 85:1654–1657PubMedCrossRef
7.
Zurück zum Zitat Lai EC, Ng IO, Ng MM, Lok AS, Tam PC, Fan ST, Choi TK, Wong J (1990) Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology 11:815–818PubMedCrossRef Lai EC, Ng IO, Ng MM, Lok AS, Tam PC, Fan ST, Choi TK, Wong J (1990) Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology 11:815–818PubMedCrossRef
8.
Zurück zum Zitat Poon RT, Fan ST (2004) Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10:S39–45PubMedCrossRef Poon RT, Fan ST (2004) Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10:S39–45PubMedCrossRef
9.
10.
Zurück zum Zitat Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC (2007) Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol 14:2817–2823PubMedCrossRef Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC (2007) Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol 14:2817–2823PubMedCrossRef
11.
Zurück zum Zitat Kim SJ, Lee KK, Kim DG (2010) Tumor size predicts the biological behavior and influence of operative modalities in hepatocellular carcinoma. Hepatogastroenterology 57:121–126PubMed Kim SJ, Lee KK, Kim DG (2010) Tumor size predicts the biological behavior and influence of operative modalities in hepatocellular carcinoma. Hepatogastroenterology 57:121–126PubMed
12.
Zurück zum Zitat Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK (2005) Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11:1086–1092PubMedCrossRef Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK (2005) Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11:1086–1092PubMedCrossRef
13.
Zurück zum Zitat el-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Yu L, Nagasue N (1997) Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma. Surgery 122:571–577PubMedCrossRef el-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Yu L, Nagasue N (1997) Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma. Surgery 122:571–577PubMedCrossRef
14.
Zurück zum Zitat Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F (2009) Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg 249:118–123PubMedCrossRef Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F (2009) Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg 249:118–123PubMedCrossRef
15.
Zurück zum Zitat Regimbeau JM, Farges O, Shen BY, Sauvanet A, Belghiti J (1999) Is surgery for large hepatocellular carcinoma justified. J Hepatol 31:1062–1068PubMedCrossRef Regimbeau JM, Farges O, Shen BY, Sauvanet A, Belghiti J (1999) Is surgery for large hepatocellular carcinoma justified. J Hepatol 31:1062–1068PubMedCrossRef
16.
Zurück zum Zitat Poon RT, Fan ST, Wong J (2002) Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 194:592–602PubMedCrossRef Poon RT, Fan ST, Wong J (2002) Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 194:592–602PubMedCrossRef
17.
Zurück zum Zitat Yang T, Zhang J, Lu JH, Yang LQ, Yang GS, Wu MC, Yu WF (2011) A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol 137:739–750PubMedCrossRef Yang T, Zhang J, Lu JH, Yang LQ, Yang GS, Wu MC, Yu WF (2011) A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol 137:739–750PubMedCrossRef
18.
Zurück zum Zitat Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF (2011) Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073–2082. doi:10.1007/s00268-011-1161-0 PubMedCrossRef Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF (2011) Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073–2082. doi:10.​1007/​s00268-011-1161-0 PubMedCrossRef
19.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196PubMedCrossRef Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196PubMedCrossRef
20.
Zurück zum Zitat Zhou YM, Li B, Xu DH, Yang JM (2011) Safety and efficacy of partial hepatectomy for huge (>/=10 cm) hepatocellular carcinoma: a systematic review. Med Sci Monit 17:RA76–83 Zhou YM, Li B, Xu DH, Yang JM (2011) Safety and efficacy of partial hepatectomy for huge (>/=10 cm) hepatocellular carcinoma: a systematic review. Med Sci Monit 17:RA76–83
21.
Zurück zum Zitat de Lope CR, Tremosini S, Forner A, Reig M, Bruix J (2012) Management of HCC. J Hepatol 56(Suppl 1):S75–87PubMedCrossRef de Lope CR, Tremosini S, Forner A, Reig M, Bruix J (2012) Management of HCC. J Hepatol 56(Suppl 1):S75–87PubMedCrossRef
22.
Zurück zum Zitat Chow PK (2012) Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria. J Gastroenterol Hepatol 27:452–457PubMedCrossRef Chow PK (2012) Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria. J Gastroenterol Hepatol 27:452–457PubMedCrossRef
23.
Zurück zum Zitat Capussotti L, Ferrero A, Vigano L, Polastri R, Tabone M (2009) Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines. Eur J Surg Oncol 35:11–15PubMedCrossRef Capussotti L, Ferrero A, Vigano L, Polastri R, Tabone M (2009) Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines. Eur J Surg Oncol 35:11–15PubMedCrossRef
24.
Zurück zum Zitat Tsoulfas G, Mekras A, Agorastou P, Kiskinis D (2012) Surgical treatment for large hepatocellular carcinoma: does size matter. ANZ J Surg 82:510–517PubMedCrossRef Tsoulfas G, Mekras A, Agorastou P, Kiskinis D (2012) Surgical treatment for large hepatocellular carcinoma: does size matter. ANZ J Surg 82:510–517PubMedCrossRef
26.
Zurück zum Zitat Wang W, Yang LY, Huang GW, Lu WQ, Yang ZL, Yang JQ, Liu HL (2004) Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer 90:2349–2355PubMedCentralPubMed Wang W, Yang LY, Huang GW, Lu WQ, Yang ZL, Yang JQ, Liu HL (2004) Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer 90:2349–2355PubMedCentralPubMed
27.
Zurück zum Zitat Yang LY, Wang W, Peng JX, Yang JQ, Huang GW (2004) Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma. World J Gastroenterol 10:3569–3573PubMed Yang LY, Wang W, Peng JX, Yang JQ, Huang GW (2004) Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma. World J Gastroenterol 10:3569–3573PubMed
28.
Zurück zum Zitat Kobayashi T, Itamoto T, Tashiro H, Amano H, Oshita A, Tanimoto Y, Kuroda S, Tazawa H, Ohdan H (2011) Tumor-related factors do not influence the prognosis of solitary hepatocellular carcinoma after partial hepatectomy. J Hepatobiliary Pancreat Sci 18:689–699PubMedCrossRef Kobayashi T, Itamoto T, Tashiro H, Amano H, Oshita A, Tanimoto Y, Kuroda S, Tazawa H, Ohdan H (2011) Tumor-related factors do not influence the prognosis of solitary hepatocellular carcinoma after partial hepatectomy. J Hepatobiliary Pancreat Sci 18:689–699PubMedCrossRef
29.
Zurück zum Zitat Zhou L, Rui JA, Wang SB, Chen SG, Qu Q (2011) Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade. Eur J Surg Oncol 37:521–525PubMedCrossRef Zhou L, Rui JA, Wang SB, Chen SG, Qu Q (2011) Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade. Eur J Surg Oncol 37:521–525PubMedCrossRef
30.
Zurück zum Zitat Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G (2005) Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 100:2708–2716PubMedCrossRef Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G (2005) Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 100:2708–2716PubMedCrossRef
31.
Zurück zum Zitat Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I (1994) Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106:720–727PubMed Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I (1994) Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106:720–727PubMed
32.
Zurück zum Zitat Li B, Yuan Y, Chen G, He L, Zhang Y, Li J, Li G, Lau WY (2010) Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome. BMC Cancer 10:535PubMedCentralPubMedCrossRef Li B, Yuan Y, Chen G, He L, Zhang Y, Li J, Li G, Lau WY (2010) Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome. BMC Cancer 10:535PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Kondo K, Chijiiwa K, Makino I, Kai M, Maehara N, Ohuchida J, Naganuma S (2005) Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 12:399–404PubMedCrossRef Kondo K, Chijiiwa K, Makino I, Kai M, Maehara N, Ohuchida J, Naganuma S (2005) Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 12:399–404PubMedCrossRef
34.
Zurück zum Zitat Fan ST, Mau LC, Poon RT, Yeung C, Leung LC, Yuen WK, Ming LC, Ng KK, Ching CS (2011) Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 253:745–758PubMedCrossRef Fan ST, Mau LC, Poon RT, Yeung C, Leung LC, Yuen WK, Ming LC, Ng KK, Ching CS (2011) Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 253:745–758PubMedCrossRef
35.
Zurück zum Zitat Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, Zhang CQ, Lau WY, Li JQ (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245:36–43PubMedCentralPubMedCrossRef Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, Zhang CQ, Lau WY, Li JQ (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245:36–43PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, Nagorney DM, Belghiti J, Naag IO, Yamaoka Y, Lauwers GY, Vauthey JN (2005) Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 140:450–457 Discussion 457–458 PubMedCrossRef Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, Nagorney DM, Belghiti J, Naag IO, Yamaoka Y, Lauwers GY, Vauthey JN (2005) Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 140:450–457 Discussion 457–458 PubMedCrossRef
37.
Zurück zum Zitat Tanaka K, Shimada H, Matsumoto C, Matsuo K, Nagano Y, Endo I, Togo S (2008) Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma. Surgery 143:607–615PubMedCrossRef Tanaka K, Shimada H, Matsumoto C, Matsuo K, Nagano Y, Endo I, Togo S (2008) Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma. Surgery 143:607–615PubMedCrossRef
38.
Zurück zum Zitat Kaibori M, Matsui Y, Hijikawa T, Uchida Y, Kwon AH, Kamiyama Y (2006) Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery 139:385–394PubMedCrossRef Kaibori M, Matsui Y, Hijikawa T, Uchida Y, Kwon AH, Kamiyama Y (2006) Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery 139:385–394PubMedCrossRef
39.
Zurück zum Zitat Cho YB, Lee KU, Lee HW, Cho EH, Yang SH, Cho JY, Yi NJ, Suh KS (2007) Anatomic versus non-anatomic resection for small single hepatocellular carcinomas. Hepatogastroenterology 54:1766–1769PubMed Cho YB, Lee KU, Lee HW, Cho EH, Yang SH, Cho JY, Yi NJ, Suh KS (2007) Anatomic versus non-anatomic resection for small single hepatocellular carcinomas. Hepatogastroenterology 54:1766–1769PubMed
40.
Zurück zum Zitat Wakai T, Shirai Y, Sakata J, Kaneko K, Cruz PV, Akazawa K, Hatakeyama K (2007) Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol 14:1356–1365PubMedCrossRef Wakai T, Shirai Y, Sakata J, Kaneko K, Cruz PV, Akazawa K, Hatakeyama K (2007) Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol 14:1356–1365PubMedCrossRef
41.
Zurück zum Zitat Yamashita Y, Taketomi A, Itoh S, Kitagawa D, Kayashima H, Harimoto N, Tsujita E, Kuroda Y, Maehara Y (2007) Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 205:19–26PubMedCrossRef Yamashita Y, Taketomi A, Itoh S, Kitagawa D, Kayashima H, Harimoto N, Tsujita E, Kuroda Y, Maehara Y (2007) Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 205:19–26PubMedCrossRef
Metadaten
Titel
Tumor Size Does Not Independently Affect Long-Term Survival after Curative Resection of Solitary Hepatocellular Carcinoma Without Macroscopic Vascular Invasion
verfasst von
Han Zhang
Shou-Xin Yuan
Shu-Yang Dai
Jin-Min Zhang
Xing Huang
Chong-De Lu
Jun-Hua Lu
Fu-Quan Wu
Wan Yee Lau
Meng-Chao Wu
Tian Yang
Feng Shen
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 4/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2365-2

Weitere Artikel der Ausgabe 4/2014

World Journal of Surgery 4/2014 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.